GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qurient Co Ltd (XKRX:115180) » Definitions » EV-to-Revenue

Qurient Co (XKRX:115180) EV-to-Revenue : 7.78 (As of Jun. 25, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Qurient Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Qurient Co's enterprise value is ₩69,979 Mil. Qurient Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩8,995 Mil. Therefore, Qurient Co's EV-to-Revenue for today is 7.78.

The historical rank and industry rank for Qurient Co's EV-to-Revenue or its related term are showing as below:

XKRX:115180' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.38   Med: 11.03   Max: 227.16
Current: 7.78

During the past 10 years, the highest EV-to-Revenue of Qurient Co was 227.16. The lowest was 4.38. And the median was 11.03.

XKRX:115180's EV-to-Revenue is ranked worse than
50.48% of 1032 companies
in the Biotechnology industry
Industry Median: 7.65 vs XKRX:115180: 7.78

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-25), Qurient Co's stock price is ₩3595.00. Qurient Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩391.27. Therefore, Qurient Co's PS Ratio for today is 9.19.


Qurient Co EV-to-Revenue Historical Data

The historical data trend for Qurient Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qurient Co EV-to-Revenue Chart

Qurient Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 45.48 11.99 9.48

Qurient Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.70 12.30 7.33 9.48 10.45

Competitive Comparison of Qurient Co's EV-to-Revenue

For the Biotechnology subindustry, Qurient Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qurient Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Qurient Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Qurient Co's EV-to-Revenue falls into.



Qurient Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Qurient Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=69979.358/8994.602
=7.78

Qurient Co's current Enterprise Value is ₩69,979 Mil.
Qurient Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8,995 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qurient Co  (XKRX:115180) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Qurient Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=3595.00/391.269
=9.19

Qurient Co's share price for today is ₩3595.00.
Qurient Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩391.27.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qurient Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Qurient Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Qurient Co (XKRX:115180) Business Description

Traded in Other Exchanges
N/A
Address
C-dong 8th Floor, 242, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, KOR, 13487
Qurient Co Ltd is a South Korea based biotech company. It is engaged in network research & development business model, integrating research and drug development programs with a new mechanism. Its pipeline products include Q301 for the treatment of atopic dermatitis; Q203 treats MDR/XDR/TDR TB, and Q701 is a drug-resistant cancer immuno-oncology.

Qurient Co (XKRX:115180) Headlines

No Headlines